Introduction
Suboptimal or inappropriate medication prescribing is highly prevalent in older people leading to an increased risk of adverse drug events (ADEs), morbidity, mortality and healthcare utilisation [1] . Potentially inappropriate medications (PIMs) have been defined as drugs with a risk of ADEs outweighing their expected clinical benefits in patients, particularly when safer therapeutic alternatives are available to treat the same condition [2] .
The prevalence of PIM prescribing among older people is high in many countries [3] [4] [5] [6] [7] . It is often determined either locally or nationally. Such an approach assumes a homogeneous spatial distribution of PIM prescribing over the study territory. Some studies, however, have identified geographic variations in prescribing quality among older people [8] [9] [10] . In addition, sociodemographic factors, such as living in rural areas, low wages and ethnicity have been associated to an increased risk of PIM prescribing [7, 11] . These results suggest that PIM prescribing may be non-uniformly spatial distributed due to variations in sociodemographic characteristics of the different areas in a given territory.
Spatial analyses are used for determining whether geographic distribution of a phenomenon is homogeneous or heterogeneous in a given territory [12] . These have been widely used in epidemiology for assessing spatial heterogeneity of disease incidence or prevalence in a given territory and identifying risk factors [13] [14] [15] .
The main objective of this study was to investigate the spatial heterogeneity of PIM prescribing prevalence in older people aged 75 and over living in a French region. The secondary objective was to determine whether prevalence for PIM prescribing varies according to healthcare supply and socioeconomic factors in this French region.
Patients and Methods

Identification of PIMs in the French Health Insurance Information System
We performed an observational study using the reimbursed medication prescriptions in community pharmacies between 1 January and 31 March 2012 in the French Nord-Pas-deCalais Region. This study included older people aged 75 and over. Details have been previously published [4] . Briefly, all prescriptions issued and reimbursed in community pharmacies were extracted over the study period. Drugs were coded according to the Anatomical Therapeutic Chemical (ATC) Classification System. Medications were classified as PIMs according to the list of Laroche [16] . The medications contained in the Laroche list are provided with their ATC-code in Supplementary Data, Appendix 1, available at Age and Ageing online. During the 3-month study period, 207,979 people aged 75 and over affiliated to the French Health Insurance Information System of the Nord-Pas-de-Calais Region had at least one reimbursed prescription containing an oral or injected drug. They represented 99.3% of eligible people and 65.6% of people aged 75 and over living in the Nord-Pas-de-Calais Region. Among them, 32.6% (n = 67,863) were receiving at least one PIM prescribing.
Data collection for spatial analysis
The French Nord-Pas-de-Calais Region is composed of 1,545 municipalities (i.e. cities, town and villages). Data were aggregated at the municipality level, which was the spatial unit for spatial analysis. The centroid for each municipality, defined as its geographical centre (latitude and longitude), was used for the spatial analysis.
The prevalence of PIM prescribing was calculated for each municipality by dividing the number of older people with a PIM prescribing during the study period by the total number of older people affiliated to the general scheme of Social Security System.
All other data were supplied by the French National Institute for Statistics and Economic Research (INSEE), Regional Health Agency (ARS) and Regional Health Observatory (ORS). The following sociodemographic data were collected for each municipality: number of inhabitants, average net taxable income, average net non-taxable income, number of unemployed or rate of unemployment (31 December 2012) and Human Development Index 4 (HDI-4). HDI was created to compare countries' levels of human development [17] . HDI-4 is a regional-scale HDI adaptation for the Nord-Pas-de-Calais Region and is a way to compare municipalities within the region taking into consideration healthcare dimension, education component and standard of living dimension. HDI-4 evaluates each of these dimensions between 0 (the worst level of development) and 1 (the best level of development).
The following data on healthcare supply were retrieved for each municipality: number of general practioners (GPs), of specialist physicians, of nurses, of physiotherapists, of home-based personal care workers. The French primary care is organised in spatial areas in accordance with the French legislation (Act of 21 December 2011). The Nord-Pas-deCalais ARS has regionally defined primary care proxy areas, in which GPs, nurses, physiotherapists and pharmacies from the largest municipalities can cover a priori the needs for all smallest municipalities. For each proxy area, healthcare supply was calculated by dividing the total number of primary care providers by the total population in the area, and was affected to all municipalities embedded in the proxy area.
Spatial analysis
The aim of this analysis was to detect significant clusters of municipalities with a high or low prevalence of PIM prescribing. We used spatial scan statistics based on the Bernoulli model to test the presence of PIM clusters and identify their location without a preselection bias [13] . These methods are powerful and well-known in the field of spatial clusters detection [14, 15, 18] .
The spatial scan statistics consisted of a two-step process: detection and inference. During the detection step, the method used a circular window, which had a flexible size and moved across the area, using as centre the centroids of the municipalities. For each window, assuming that the number of PIM prescribing was binomially distributed, a likelihood function could be computed. The window maximising the likelihood function was defined as the most likely cluster.
During the inference step the null hypothesis corresponded to the absence of clusters and referred to the following statement: 'the risk of PIM prescribing was constant throughout all municipalities'. To test the null hypothesis, a likelihood ratio (LLR) test was used. The numerator of LLR was the likelihood function value associated with the most likely cluster and the denominator was the value of likelihood function under null hypothesis. The distribution of LLR was unknown and the method used 9,999 Monte Carlo random replications under null hypothesis to obtain a P-value. The calculations were performed using the SaTScan software [19] and a cluster was defined as significant when its associated one-sided P-value was less than 0.05. Their significance was evaluated by computing the P-value adjusted for Most Likely Cluster according to Zhang's method [20] . A relative risk (RR) was associated to each significant cluster.
Statistical analysis
Quantitative variables were described by median, interquartile range (IQR), minimum and maximum because of skewed distributions. According to the results of the spatial analysis, all municipalities in the study region were divided into three groups: municipalities included in clusters with a high PIM prevalence, those in clusters with a low PIM prevalence and those not included in a cluster. Since characteristics of healthcare supply in these three clusters of municipalities did not follow a normal distribution, a nonparametric test of Kruskal-Wallis was used for comparing them. Dunn test with a Bonferoni correction was used for post-hoc comparisons between groups. The statistical analyses were performed using SAS software (SAS Institute, Gary, North Carolina, US). Comparative analyses were conducted with a significance threshold of tests set at 5%.
Results
Municipalities in the Nord-Pas-de-Calais Region
Characteristics were collected from 1,545 municipalities and 170 primary care areas and are summarised in Supplementary Data, Appendix 1, available at Age and Ageing online. Population and healthcare supply were inconsistent among municipalities. Population ranged from 16 to 228,652 inhabitants in municipalities. Villages (population <2,000 inhabitants) accounted for almost 75% of municipalities. Numerous villages did not have any GP, physiotherapist, pharmacy and home-based personal care workers. There were wide disparities in healthcare supply among municipalities. For example, the number of GPs ranged from 0 to 13.5 GPs per 1,000 inhabitants among municipalities. There were also disparities between primary care proxy areas, but to a lesser extent. The number of GPs ranged from 0.42 to 2.02 GPs per 1,000 inhabitants. The following analyses are based on healthcare supply within the primary care proxy areas.
The average taxable income may be seen as an indirect indicator of the municipality wealth and varied substantially (from 12,456 to 66,841 €/year). Conversely, an average non-taxable income may be seen as an indirect indicator of the municipality poverty and varied at a ratio 1:2 (from 6,894 to 16,636 €/year). Unemployment rate and HDI-4 also indicated large disparities in human development. The median unemployment rate was 57.7/1,000 inhabitants (IQR: 
Significant differences in PIM prevalence between clusters of municipalities
The four drug classes of PIMs most involved in the total population were cerebral vasodilators (29.8%), drugs with anticholinergic effect (24.2%), benzodiazepines with a long half-life (22.0%) and central antihypertensive agents (19.4%). The spatial analysis identified 26 clusters with PIM prevalence significantly different from the rest of the region. These 26 clusters encompassed 191 municipalities (12.4%) and were divided into two groups: a group of 16 clusters including municipalities with a high PIM prevalence and a group of 10 clusters including municipalities with a low PIM prevalence. Their spatial distribution in the Nord-Pasde-Calais Region is displayed in Figure 1 . Clusters' characteristics (observed and expected cases, P-value, geographical location) are summarised in Table 1 . RR of PIM prescribing for clusters with a high PIM prevalence ranged from 1.12 to 1.65. For example, people aged 75 and over living in municipalities located in cluster 3 were 1.51 times more likely to have a PIM prescription than people aged 75 and over living in the rest of the region (P < 0.0001).
Characteristics of municipalities with a high or low PIM prevalence
Municipalities of the entire study region were classified into three groups according to PIM prevalence: normal, high or low. Comparative results between these groups are presented in Table 2 . Municipalities with a high PIM prevalence were mainly characterised by a higher unemployment rate, a lower HDI-4, and a lower net taxable and nontaxable income than those in the rest of the region. The number of GPs and of specialist physicians per 1,000 inhabitants was similar to the one in the rest of the region. These municipalities had a greater number of graduate nurses, pharmacies and home-based care workers than in the rest of the region. Municipalities with a low PIM prevalence were mainly characterised by a larger population, a higher net taxable income, a higher HDI-4 and a greater number of GPs and specialist physicians per 1,000 inhabitants compared to the rest of the region.
Discussion
Our spatial study conducted in a French region reveals a significant geographic variation in PIM prescribing among older people aged 75 and over. Areas with a high PIM prevalence in the study territory were mainly socioeconomically deprived, despite equal or greater healthcare supply compared to the rest of the region. Those with a low PIM prevalence were more densely populated with more wealthy people. This suggests that the socioeconomic characteristics of a given geographic area may influence the prescribing behaviour of physician and the quality of prescribing in older patients, even when healthcare supply is adequate.
Geographic variations in prescribing quality among older people have been described in other studies [8] [9] [10] 21] . PIM prescribing prevalence has been shown to vary substantially between the four national regions and the Dartmouth hospital-referral regions [8, 9] . Substantial variation in the use of antibiotics across regions and states were also identified [10] . These studies compared prevalence of inappropriate prescribing in predefined geographical areas such as states or regions. Such an approach has limitations because it is only descriptive and it does not perform any statistical inference on the spatial distribution to confirm the significance of the geographic variation [12] . Scan statistics tackle this issue by identifying spatial clusters, which size and location are not predefined and by testing their statistical significance. The use of scan statistics in our study confirmed a significant geographic variation in PIM prescribing and revealed that older patients living in clusters of high PIM prevalence were up to 1.65 times more likely to have a PIM prescription than those living in the rest of the region.
Such a geographic variation suggests that PIM prescribing may be influenced by other factors than patients' characteristics. Risk factors of PIM prescribing have been widely investigated on patients' characteristics. The most common patients' characteristics associated with an increased likelihood of PIM prescribing were polypharmacy, female gender and age [7, 11, 22, 23] . Other findings suggest that comorbidities, psychiatric disorders, ethnicity, social deprivation and living areas (rural versus urban) may have an influence [7, 11] . This study sheds new light on this issue. Our innovative approach investigated the association between socioeconomic characteristics of a given geographic area and PIM prevalence. Municipalities with a high PIM prevalence were characterised by social deprivation indicators: greater poverty, a higher unemployment rate and a lower HDI-4. The association between social deprivation and higher PIM prevalence could not be explained by a lower healthcare supply in these areas, as the number of GPs, nurses and pharmacists was similar or even higher than in the rest of the region. Conversely, those with a low PIM prevalence were mainly characterised by better RR within the cluster compared with the rest of the study region. a Geographic location of clusters is displayed Figure 1 . b Radius, distance between the cluster centroid and its boundaries. development indicators, such as larger and wealthier populations, as well as a higher HDI-4. Negative socioeconomic factors are related to a lower self-reported health, a higher prevalence of chronic diseases and a higher mortality rate in Europe [24] [25] [26] . The utilisation of the healthcare services by low-income patients is specific as these patients visit more frequently GPs [27, 28] . However, the relationship between socioeconomic factors and the use of prescription medications has scarcely been studied. A Danish survey carried out in 19,000 primiparous women showed that the use of prescription medications during pregnancy was linked to their education level and socioeconomic status [29] . An Irish study categorised 95,055 older patients as relatively deprived or relatively affluent individuals, and showed that suboptimal prescribing was more prevalent among the relatively deprived cohort [30] . Consistent with these previous findings, our study showed that PIM prescribing is more prevalent in municipalities with social deprivation. This geographic presentation of social deprivation may be worthwhile in terms of public health. Health policies could prioritise interventions dedicated to reduce inappropriate prescribing, such as medication reviews, in the areas at higher risk of PIM prescribing.
Some limitations of this study should be mentioned. Our results are closely related to the standard we used to identify PIMs. We choose to use the list of Laroche because it is more appropriate for France than the Beers criteria. Another limitation is that HDI-4 is a regional indicator developed on the basis of a well-recognised indicator, but not validated. As a result, it should be interpreted with caution. An additional limitation is that our approach assumes that the older people used the healthcare supply in their municipality and that they just got their prescriptions in the municipality where they live. Information about possible cross-border behaviour of patient was not available from the data and this potential confounder could not be acknowledged in the analysis. However, such cross-border behaviour would not change the main result of our studies, namely the identification of clusters of high or low PIM prevalence. Finally, our results were obtained in a given geographic area, the French Nord-Pas-de-Calais Region. Organisation of primary care, health policies, medications reimbursement vary between countries and provinces, so our findings may be specific of the geographic area under investigation. Further studies conducted in other areas and other countries with different cultural environments and healthcare organisations are needed to confirm the relationship between social deprivation and PIM prevalence.
In conclusion, our study has shown that PIM prevalence is heterogeneous within a given area. Social deprivation and underdevelopment were identified as the main factors linked to the municipalities with a high PIM prevalence. Our findings suggest that quality of prescribing depends on the sociodemographic environment in which it is ordered.
Key points
• The prevalence of potentially inappropriate medications (PIMs) among older people is high and heterogeneous within a given area.
• Socioeconomic factors seem to be strongly associated with high or low prevalence of PIMs.
• Markers of healthcare supply seem to be weakly associated with high or low prevalence of PIMs.
Supplementary data
Supplementary data mentioned in the text are available to subscribers in Age and Ageing online.
